Haemotronic
Haemotronic S.p.A., commonly referred to as Haemotronic, is a leading player in the medical device industry, headquartered in Italy. Founded in 1982, the company has established a strong presence in Europe and beyond, specialising in innovative solutions for blood management and transfusion safety. Haemotronic is renowned for its advanced blood collection and processing systems, which are designed to enhance patient safety and improve clinical outcomes. Their unique approach combines cutting-edge technology with a commitment to quality, positioning them as a trusted partner in healthcare. With a focus on research and development, Haemotronic has achieved significant milestones, including numerous certifications and recognitions that underscore its market leadership. The company continues to expand its influence, providing essential products that meet the evolving needs of the medical community.
DitchCarbon Score
How does Haemotronic's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Haemotronic's score of 13 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Haemotronic's reported carbon emissions
In 2023, Haemotronic reported total carbon emissions of approximately 31,206,000 kg CO2e, comprising 4,661,000 kg CO2e from Scope 1 and 26,546,000 kg CO2e from Scope 2 emissions. This represents a slight decrease in Scope 1 emissions compared to 2022, where they were about 4,735,000 kg CO2e, while Scope 2 emissions increased from approximately 23,678,000 kg CO2e in 2022. In 2022, the total emissions were around 28,413,000 kg CO2e, with Scope 1 emissions at 4,735,000 kg CO2e and Scope 2 emissions at 23,678,000 kg CO2e. The 2021 figures showed total emissions of about 21,140,000 kg CO2e, with Scope 1 at 2,657,000 kg CO2e and Scope 2 at 18,483,000 kg CO2e. Despite these figures, Haemotronic has not disclosed specific reduction targets or initiatives as part of their climate commitments. The absence of documented reduction targets suggests a need for further clarity on their long-term climate strategy.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 2,657,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 18,483,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Haemotronic is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
